Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro

Sheau Pey Wang; Shigeru Iwata; Shingo Nakayamada; Kei Sakata; Kunihiro Yamaoka; Yoshiya Tanaka

doi:10.1136/annrheumdis-2014-205615

Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro

Sheau Pey Wang, Shigeru Iwata, Shingo Nakayamada, Kei Sakata, Kunihiro Yamaoka, Yoshiya Tanaka

研究成果: Letter › 査読

本文言語	English
ページ（範囲）	2213-2215
ページ数	3
ジャーナル	Annals of the rheumatic diseases
巻	73
号	12
DOI	https://doi.org/10.1136/annrheumdis-2014-205615
出版ステータス	Published - 2014 12月 1
外部発表	はい

ASJC Scopus subject areas

生化学、遺伝学、分子生物学（全般）
リウマチ学
免疫アレルギー学
免疫学

文献へのアクセス

10.1136/annrheumdis-2014-205615

他のファイルとリンク

引用スタイル

@article{0bc87ac32ac444b889fbc7def4daf876,

title = "Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro",

author = "Wang, {Sheau Pey} and Shigeru Iwata and Shingo Nakayamada and Kei Sakata and Kunihiro Yamaoka and Yoshiya Tanaka",

year = "2014",

month = dec,

day = "1",

doi = "10.1136/annrheumdis-2014-205615",

language = "English",

volume = "73",

pages = "2213--2215",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "12",

}

TY - JOUR

T1 - Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro

AU - Wang, Sheau Pey

AU - Iwata, Shigeru

AU - Nakayamada, Shingo

AU - Sakata, Kei

AU - Yamaoka, Kunihiro

AU - Tanaka, Yoshiya

PY - 2014/12/1

Y1 - 2014/12/1

UR - http://www.scopus.com/inward/record.url?scp=84922226607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922226607&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2014-205615

DO - 10.1136/annrheumdis-2014-205615

M3 - Letter

C2 - 25157177

AN - SCOPUS:84922226607

SN - 0003-4967

VL - 73

SP - 2213

EP - 2215

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - 12

ER -